MD+DI Online is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

CellSearch (2009 Prix Galien USA Winner)

    Arrow  backCellSearch

CellSearch (2009 Prix Galien USA Winner)

CellSearch from Johnson & Johnson's Janssen Diagnostics is the first and only actionable test for detecting circulating tumor cells in cancer patients. Detecting such CTCs is important because their presence indicates decreased odds of survival for metastatic breast, colorectal, or prostate cancer patients, according to Janssen. The tests, then, are an important new tool in the toolbox in the fight against cancer. 

The 10 Most Promising Medical Technologies of 2016 >>

And vote in our survey >>

[Image courtesy of Janssen Diagnostics]

Hide comments
account-default-image

Comments

  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Publish